Prostate Cancer 'cell Of Origin' Identified

Prostate cancer 'cell of origin' identified

For researchers, a key to studying any cancer is finding its "cell of origin." Now scientists at the University of California at Los Angeles say they've found just that -- a specific type of cell that gives rise to prostate cancer. Cancer - Prostate cancer - Health - Conditions and Diseases - University of California Los Angeles

RELATED ARTICLES
  • Most people aren't meeting exercise guidelines
    Most adults in the USA aren't meeting the federal physical activity recommendations for both aerobic exercise and muscle-strengthening activity, according to government statistics out today. About 79% of adults don't meet the physical activity guidelines that advise getting at least 2½ hours a week of moderate-intensity aerobic activity such as brisk walking, or one hour and 15 minutes a week of vigorous-intensity aerobic activity, such as jogging. More
  • US suicide rate rose sharply among middle-aged
    Health officials say suicides among middle-aged Americans climbed at a startling rate over the past decade, a period that included the recession. Overall, the suicide rate for the age group jumped 28 percent from 1999 to 2010. And among whites, it shot up 40 percent.... More
  • Cost of feeding a family of four: $146 to $289 a week
    Latest statistics give a range of prices for feeding a family of four a healthy diet. The cost of feeding a family of four a healthy diet can run $146 to $289 a week, according to the latest numbers from the U.S. More
  • Russia charging NASA $70 million per rocket seat
    NASA is blaming Congress for the need to pay $424 million more to Russia to get U.S. astronauts into space. More
  • 2-year-old girl gets windpipe made from stem cells
    A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.... More
BING NEWS:
  • Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML
    Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) today announced that interim analysis data from the Phase 2 OPTIC ( O ptimizing P onatinib T reatment I n C ML) trial will be presented ...
    05/29/2020 - 1:01 am | View Link
  • Cancer cell therapies: the clinical trial landscape
    Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA. Pipeline trends. The current global cancer cell therapy pipeline includes 1,483 active agents, 472 more than last year.
    05/26/2020 - 1:22 am | View Link
  • A Hidden Origin Story of the CBD Craze
    The cure-all debate over the cannabis compound has distracted from the serious — and seriously odd — back story of how cannabidiol conquered the country.
    05/23/2020 - 8:11 am | View Link
  • Biomarkers may predict response to immunotherapy in prostate cancer
    Answer: We were looking at a simple question of whether we could detect T-cell responses to cancer neoantigens. Neoantigens are mutated proteins expressed on the cancer cell that can be recognized ...
    05/12/2020 - 9:13 am | View Link
  • Twist Bioscience Corporation (TWST) CEO Emily Leproust on Q2 2020 Results
    Q2 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Emily Leproust - Chief Executive Officer ...
    05/10/2020 - 5:58 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News